Last reviewed · How we verify
NCT03350308: IMHOTEP
Prediction of Risk of Hypotension in Hemodialysis
trial testing hemodialysis in Chronical Kidney Disease in 60 participants. Completed in 27 December 2023.
27 December 2023
Quick facts
| Lead sponsor | University Hospital, Clermont-Ferrand |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 January 2015 |
| Primary completion | 27 December 2023 |
| Estimated completion | 27 December 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- hemodialysis
Conditions studied
- Chronical Kidney Disease — all drugs for Chronical Kidney Disease →
- Hypotension — all drugs for Hypotension →
- Residual Blood Volume — all drugs for Residual Blood Volume →
- Hemodialysis — all drugs for Hemodialysis →
Sponsor
University Hospital, Clermont-Ferrand
Who can join
18 and older, any sex, with Chronical Kidney Disease or Hypotension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration. The secondary objective is to study the impact of dysfunction in the mechanisms of compensation for decreased blood volume (heart disease, neuropathy, drugs) on the risk of intradialytic hypotension.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Continuous monitoring of relative blood volume allows real-time assessment of intradialytic hypotension risk.
Aniort J, Bachelet T, Seris P, Dolley-Hitze T, et al · · 2026 · PMID 42027896 · DOI 10.1093/ckj/sfag052
Verify or expand the search:
- PubMed search for NCT03350308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of hemodialysis
Trials testing the same drug.
- NCT07189741 — Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy · not yet recruiting
- NCT05429515 — Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury · Phase 4 · not yet recruiting
- NCT02532621 — Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study] · NA · completed
- NCT03227770 — The Benefit of Hemodialysis Plus Hemoperfusion on Mortality · NA · completed
Other recruiting trials for Chronical Kidney Disease
Currently open trials in the same condition.
- NCT06883968 — Therapeutic Exercise Programme to Improve the Functional Capacities, Depression and Anxiety of Patients with Chronic Kid · NA · active not recruiting
Other University Hospital, Clermont-Ferrand trials
Trials by the same sponsor.
- NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
- NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
- NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
- NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
- NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03350308 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03350308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing